South Africa reports new mpox cases; deaths rise to three

26 Jun 2024

The Department of Health confirms that the country has recorded three additional positive cases of mpox (formerly known as monkeypox) and one death. Efforts to curb the spread of this infection are ongoing in the affected communities nationwide.

Source: Wikipedia.

The latest cases include a 40-year-old male from Ladysmith in KwaZulu-Natal who presented with mpox-like symptoms, including a rash all over his body, and who never presented at the hospital. He passed away at home and the results came back positive for mpox on Sunday, 23 June 2024.

The other two cases were confirmed in Gauteng including a 43-year-old man who was diagnosed on Saturday, 22 June 2024 at a local private health facility in Johannesburg, and a 29-year-old male diagnosed in Mamelodi health facility on Friday, 21 June 2024. They presented with symptoms indicative of disease and had no international travel history.

This brings the total number of laboratory-confirmed cases of mpox in South Africa to 16 since the outbreak of the disease in May 2024. Eight cases from KwaZulu-Natal, seven cases from Gauteng, and one from Western Cape. All cases are males, aged between 23 to 43 years old. The number of mpox-related deaths has also increased to three.

The department, working with provinces and other stakeholders in the sector, has embarked on health education with funeral parlours on how to handle the human remains of the demised due to suspected and confirmed mpox.

The department would like to allay fears of possible travel restrictions or lockdowns due to mpox outbreak because the World Health Organization has not recommended any travel restrictions.

However, it is important for travellers from mpox endemic countries to seek healthcare if they are ill and to alert health officials about their travel for clinical guidance.

Individuals, families and communities are urged to support all those who experience mpox-like symptoms to present at their nearest healthcare facilities without delay for screening and diagnosis, instead of self-diagnosis and using over-the-counter medication.

Anyone can contract mpox regardless of age, gender, sexual orientation and race.

Mpox is preventable and manageable, and treatment for both mild and severe cases is available. People at high risk include those living with chronic conditions such as HIV, TB and diabetes.